OHTAC recommendation: Care for drug-refractory epilepsy in Ontario

Ontario Health Technology Assessment Series

Volumn 12, Issue 17, 2012, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85041995584     PISSN: 19157398     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ahmed SN, Wiebe S, Mann C, Ohinmaa A. Telemedicine and epilepsy care - a Canada wide survey. Can J Neurol Sci. 2010;37:814-818.
2. World Health Organization. Atlas: Epilepsy care in the world. Geneva (CH): World Health Organization; 2005. p. 91.
3. Canadian Institute for Health Information. The Burden of Neurological Diseases, Disorders and Injuries in Canada. Ottawa (ON): CIHI; 2007.
4. Carne RP, O'Brien TJ, Kilpatrick CJ, MacGregor LR, Hicks RJ, Murphy MA, et al. MRI-negative PET- positive temporal lobe epilepsy: a distinct surgically remediable syndrome. Brain. 2004;127:2276-2285.
5. Chugani HT, Kumar A, Kupsky W, Asano E, Sood S, Juhász C. Clinical and histopathologic correlates of 11C-alpha-methyl-l-tryptophan (AMT) PET abnormalities in children with intractable epilepsy. Epilepsia. 2011; Epub 2011 May 13.
6. De Flon P, Kumlien E, Reuterwall C, Mattsson P. Empirical evidence of underutilization of referrals for epilepsy surgery evaluation. Eur J Neurol. 2010;17:619-625.
7. Drewel EH, Bell DJ, Austin JK. Peer difficulties in children with epilepsy: association with seizure, neuropsychological, academic, and behavioral variables. Child Neuropsychol. 2009;15:305-320.
8. Elliott IM, Lach L, Smith ML. I just want to be normal: a qualitative study exploring how children and adolescents view the impact of intractable epilepsy on their quality of life. Epilepsy Behav. 2005;7:664- 678.
9. Go C, Snead III OC. Pharmacological intractable epilepsy in children: diagnosis and pre-operative evaluation. Neurosurg Focus. 2008;25:E2.
10. Gruman J, VonKorff M, Reynolds J, Wagner EH. Organizing health care for people with seizures and epilepsy. J Ambul Care Manage. 1998;21:1-17.
11. Hamiwka LD, Singh N, Niosi J, Wirrell EC. Diagnostic inaccuracy in children referred with "first seizure": role for a first seizure clinic. Epilepsia. 2007;48:1062-1066.
12. Hermann B, Meador KJ, Gaillard WD, Cramer JA. Cognition across the lifespan: antiepileptic drugs, epilepsy, or both. Epilepsy Behav. 2010 Jan;17(1):1-5.
13. Hinnell C, Williams J, Metcalfe A, Patten SB, Parker R, Wiebe S, et al. Health status and health-related behaviors in epilepsy compared to other chronic conditions--a national population-based study. Epilepsia. 2010;51:853-861.
14. Ibrahim GM, Fallah A, Snead OC 3rd, Elliott I, Drake JM, Bernstein M, et al. Ethical issues in surgical decision making concerning children with medically intractable epilepsy. Epilepsy Behav. 2011;22(2): 154-157.
15. Jones JE, Austin JK, Caplan R, Dunn D, Plioplys S, Salpekar JA. Psychiatric disorders in children and adolescents who have epilepsy. Pediatr Rev. 2008;29:e9-e14.
16. Kobau R. Zahran H. Thurman DJ. Zack MM. Henry TR. Schachter SC. Price PH. Epilepsy surveillance among adults--19 States, Behavioral Risk Factor Surveillance System, 2005. MMWR Surveill Summ. 2008;57:1-20.
17. Krumholz A. Driving issues in epilepsy: past, present, and future. Epilepsy Curr. 2009 Mar;9:31-35.
18. Krumholz A, Wiebe S, Gronseth G, Shinnar S, Levisohn P, Ting T, et al. Practice Parameter: evaluating an apparent unprovoked first seizure in adults (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2007;69:1996-2007.
19. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342:314-319.
20. McNelis AM, Dunn DW, Johnson CS, Austin JK, Perkins SM. Academic performance in children with new-onset seizures and asthma: a prospective study. Epilepsy Behav. 2007;10;311-318.
21. Murray CJ, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ. 1994;72:495-509.
22. Neligan A, Bell GS, Shorvon SD, Sander JW. Temporal trends in the mortality of people with epilepsy: a review. Epilepsia. 2010;51:2241-2246.
23. Sherman EM. Maximizing quality of life in people living with epilepsy. Can J Neurol Sci. 2009;36 Suppl 2:S17-S24.
24. Stefan H, Rampp S, Knowlton RC. Magnetoencephalography adds to the surgical evaluation process. Epilepsy Behav. 2011 Feb;20(2):172-177.
25. Swarztrauber K. Barriers to the management of patients with surgically remediable intractable epilepsy. CNS Spectr. 2004;9:146-152.
26. Swarztrauber K, Dewar S, Engel J Jr. Patient attitudes about treatments for intractable epilepsy. Epilepsy Behav. 2003;4:19-25.
27. Tellez-Zenteno JF, Dhar R, Wiebe S. Long term outcomes in epilepsy surgery: a systematic review and meta-analysis. Brain. 2005;128:1188-1198.
28. Tellez-Zenteno JF, Pondal-Sordo M, Matijevic S, Wiebe S. National and regional prevalence of selfreported epilepsy in Canada. Epilepsia. 2004;45:1623-1629.
29. Theodore WH, Spencer SS, Wiebe S, Langfitt JT, Ali A, Shafer PO, et al. Epilepsy in North America: a report prepared under the auspices of the global campaign against epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization. Epilepsia. 2006;47:1700-1722.
30. Wiebe S. Still an elusive target: guiding practice for epilepsy surgery. Neurology. 2010;75:678-9.
31. Wiebe S, Bellhouse DR, Fallahay C, Eliasziw M. Burden of epilepsy: the Ontario Health Survey. Can J Neurol Sci. 1999;26:263-270.
32. Wiebe S, Blume WT, Girvin JP, Eliasziw M; Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345:311-318.